Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma

N. H. Mulder; DTh Sleijfer; Heimen Schraffordt Koops; Elisabeth G.E. de Vries; P.H.B. Willemse

doi:10.1038/bjc.1992.61

Back to search

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma

N. H. Mulder, DTh Sleijfer, Heimen Schraffordt Koops, Elisabeth G.E. de Vries, P.H.B. Willemse

DOI: 10.1038/bjc.1992.61

British Journal of Cancer

Data up to Jan 2025

Published1992

Citations18

References5

Fields

Medicine Biology Cancer research Oncology Internal medicine

Total Citations Per Year

Abstract

References (5)

Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites.

1988 • 154 citations

Three consecutive phase II studies of recombinant interferon alfa–2a in advanced malignant melanoma. Updated analyses

1987 • 51 citations

Systemic chemotherapy for metastatic melanoma.

1988 • 50 citations

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma

1990 • 12 citations

Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma

1989 • 9 citations

Cited By (0)

Loading...